Post-Transplant Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in HLA Matched Sibling or Matched Unrelated Donor Transplant for Patients With Acute Leukemia, on Behalf of ALWP-EBMT

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-018-0586-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Post-Transplant Cyclophosphamide (PTC) as Sole Graft Versus Host Disease (GVHD) Prophylaxis in Patients Undergoing HLA Matched Sibling Donor Stem Cell Transplant (SCT) for Severe Aplastic Anemia (SAA)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Different Risk Factors of Acute and Chronic Graft-Versus-Host Disease With Conventional Prophylaxis and Posttransplantation Cyclophosphamide in Matched Related and Unrelated Donor Transplantations

Cellular Therapy and Transplantation
TransplantationMolecular Medicine
2018English

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated With Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Double Unit Umbilical Cord Blood Transplant for Adults With Acute Leukemia and Myelodysplastic Syndrome Results in Comparable Outcome as Matched Sibling or Unrelated Donor Transplant Only After Myeloablative Conditioning but Not Reduced Intensity Conditio

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Ex Vivo T Cell Depleted HLA-Matched PBSCT With Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) With Tacrolimus and Methotrexate (Tac/Mtx) GVHD Prophylaxis in Patients With AML Undergoing Transplantation From Matched Related or Unrelated Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Risk Factors for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation From Matched Related or Unrelated Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy